GC69484
Mogamulizumab
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb) that removes fucosylation and can eliminate tumor cells through antibody-dependent cell-mediated cytotoxicity (ADCC)· Mogamulizumab is being studied for its potential use in cancer, adult T-cell leukemia/lymphoma (ATLL), and cutaneous T-cell lymphoma (CTCL)
ChemicalCAS1159266-37-1
- CAS number
- 1159266-37-1
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC69484
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il